These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 38435821)

  • 1. A landscape of recent advances in lipid nanoparticles and their translational potential for the treatment of solid tumors.
    Paun RA; Jurchuk S; Tabrizian M
    Bioeng Transl Med; 2024 Mar; 9(2):e10601. PubMed ID: 38435821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid Nanoparticle-mRNA Formulations for Therapeutic Applications.
    Wang C; Zhang Y; Dong Y
    Acc Chem Res; 2021 Dec; 54(23):4283-4293. PubMed ID: 34793124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micro-syringe chip-guided intratumoral administration of lipid nanoparticles for targeted anticancer therapy.
    Kim J; Song S; Gwak M; Cho H; Yun WS; Hwang N; Kim J; Lee JS; Kim DH; Kim H; Jeon SI; Kim TI; Kim K
    Biomater Res; 2023 Oct; 27(1):102. PubMed ID: 37845762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid Nanoparticles─From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement.
    Tenchov R; Bird R; Curtze AE; Zhou Q
    ACS Nano; 2021 Nov; 15(11):16982-17015. PubMed ID: 34181394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chelation, formulation, encapsulation, retention, and in vivo biodistribution of hydrophobic nanoparticles labelled with
    Hervella P; Dam JH; Thisgaard H; Baun C; Olsen BB; Høilund-Carlsen PF; Needham D
    J Control Release; 2018 Dec; 291():11-25. PubMed ID: 30291986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing.
    Qiu M; Li Y; Bloomer H; Xu Q
    Acc Chem Res; 2021 Nov; 54(21):4001-4011. PubMed ID: 34668716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Updates on Applications of Lipid-Based Nanoparticles for Site- Specific Drug Delivery.
    Agrawal S; Garg A; Varshney V
    Pharm Nanotechnol; 2022; 10(1):24-41. PubMed ID: 35249522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemistry of Lipid Nanoparticles for RNA Delivery.
    Eygeris Y; Gupta M; Kim J; Sahay G
    Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver.
    Zhang R; El-Mayta R; Murdoch TJ; Warzecha CC; Billingsley MM; Shepherd SJ; Gong N; Wang L; Wilson JM; Lee D; Mitchell MJ
    Biomater Sci; 2021 Feb; 9(4):1449-1463. PubMed ID: 33404020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymer-Lipid Hybrid Nanoparticles: A Next-Generation Nanocarrier for Targeted Treatment of Solid Tumors.
    Rizwanullah M; Alam M; Harshita ; Mir SR; Rizvi MMA; Amin S
    Curr Pharm Des; 2020; 26(11):1206-1215. PubMed ID: 31951163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid nanoparticles for siRNA delivery in cancer treatment.
    El Moukhtari SH; Garbayo E; Amundarain A; Pascual-Gil S; Carrasco-León A; Prosper F; Agirre X; Blanco-Prieto MJ
    J Control Release; 2023 Sep; 361():130-146. PubMed ID: 37532145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.
    Tam A; Kulkarni J; An K; Li L; Dorscheid DR; Singhera GK; Bernatchez P; Reid G; Chan K; Witzigmann D; Cullis PR; Sin DD; Lim CJ
    Eur J Pharm Sci; 2022 Sep; 176():106234. PubMed ID: 35688311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latest Delivery Advancements of Lipid Nanoparticles for Cancer Treatment.
    Chauhan S; Nagpal K
    Assay Drug Dev Technol; 2024 Jul; ():. PubMed ID: 38968367
    [No Abstract]   [Full Text] [Related]  

  • 14. Lipid-based nanoparticle formulations for small molecules and RNA drugs.
    Ickenstein LM; Garidel P
    Expert Opin Drug Deliv; 2019 Nov; 16(11):1205-1226. PubMed ID: 31530041
    [No Abstract]   [Full Text] [Related]  

  • 15. Current issues of RNAi therapeutics delivery and development.
    Haussecker D
    J Control Release; 2014 Dec; 195():49-54. PubMed ID: 25111131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid Nanoparticle (LNP) Chemistry Can Endow Unique
    Johnson LT; Zhang D; Zhou K; Lee SM; Liu S; Dilliard SA; Farbiak L; Chatterjee S; Lin YH; Siegwart DJ
    Mol Pharm; 2022 Nov; 19(11):3973-3986. PubMed ID: 36154076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications.
    Jeong M; Lee Y; Park J; Jung H; Lee H
    Adv Drug Deliv Rev; 2023 Sep; 200():114990. PubMed ID: 37423563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of DOTAP/chol Cationic Lipid Nanoparticles for mRNA, pDNA, and Oligonucleotide Delivery.
    Sun M; Dang UJ; Yuan Y; Psaras AM; Osipitan O; Brooks TA; Lu F; Di Pasqua AJ
    AAPS PharmSciTech; 2022 May; 23(5):135. PubMed ID: 35534697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery.
    Battaglia L; Gallarate M
    Expert Opin Drug Deliv; 2012 May; 9(5):497-508. PubMed ID: 22439808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stabilization of Ostwald ripening in low molecular weight amino lipid nanoparticles for systemic delivery of siRNA therapeutics.
    Gindy ME; Feuston B; Glass A; Arrington L; Haas RM; Schariter J; Stirdivant SM
    Mol Pharm; 2014 Nov; 11(11):4143-53. PubMed ID: 25317715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.